Medical/Pharmaceuticals

United Imaging Goes "All-in" for Nashville

HOUSTON, July 28, 2021 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, makes its debut at HealthTrust University and its in-person debut at AHRA inNashville over the next two weeks. At both events, the company will focus on several unique ...

2021-07-28 20:00 1306

GenScript Announces Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Kit

PISCATAWAY, N.J., July 28, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, announced today that the U.S. Patent and Trademark Office (USPTO) has issued a notice of allowance...

2021-07-28 19:30 5023

I-Mab Announces IND Acceptance for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China

* Efineptakin alfa in combination with pembrolizumab induced 27.8% ORR in metastatic TNBC patients in a phase1b/2 trial in South Korea * Efineptakin alfa in patients with GBM showed a 83.3% survival ratio over one year in a phase 1 trial in the U.S. SHANGHAI and GAITHERSBURG, Md., July 28, 20...

2021-07-28 19:15 4276

Kintor Pharmaceutical Announces Dosing of First Batch of Subjects in Phase I Clinical Trial of GT20029 in China

SUZHOU, China, July 28, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company has dosed the first batch of subjects in its phase I clinical trial of...

2021-07-28 13:47 5049

Zepp Health Invests $2.4M to Lead neuro42's Series A Round

CUPERTINO and SAN FRANCISCO, Calif., July 27, 2021 /PRNewswire/ -- Zepp Health Corp. (NYSE: ZEPP), and neuro42, Inc. today announced that Zepp Health is investing$2.4 million to lead the $6.5 million Series A funding round for the development of MRI and robotics technology that allows physicians ...

2021-07-28 04:00 12180

I-Mab Announces Preliminary Proposal for Potential Dual Listing on the STAR Market of the Shanghai Stock Exchange

SHANGHAI and GAITHERSBURG, Md., July 27, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that onJuly 27, 2021, the Board of Directors of the Comp...

2021-07-27 20:35 11363

iXensor Levels Up PixoTest Covid-19 Ag Test With The Launch Of PixoHealth Data Management Platform As The Security Solution For The New Normalcy

* The GDPR-compliant PixoHealth Pass Admin Solution works with PixoTest® POCT COVID-19 Antigen Test to help organizations maintain COVID-19 free environments * The PixoTest® POCT COVID-19 Antigen Test detects the key SARS-CoV-2 variants, including Alpha, Beta, Gamma and Delta * Connected poi...

2021-07-27 19:32 1568

PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference

DAEJEON, South Korea, July 26, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next generation antibody therapeutics, announced today that the company is invited to deliver a video presentation at H.C Wainwright Ophthalmolo...

2021-07-26 20:00 1407

HBM Presents Phase I Data on Next-Generation Anti-CTLA-4 Antibody at ESMO Congress 2021

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, July 26, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) today announced that the abstract detailing clinical data from its Australian phase I study of next-generation anti-CTLA-4 antibody in patients with advanced solid tumo...

2021-07-26 19:11 4639

Health and senior care conference held in southwest China's Chongqing Shizhu

CHONGQING, China, July 23, 2021 /PRNewswire/ -- The 5th China Health and Senior Care Conference was heldJuly 19 in Huangshui Town in Shizhu county in southwest China's Chongqing, according to the Publicity Department of Shizhu County. The three-day event focused on traditional Chinese medicine (T...

2021-07-23 18:52 1132

LG SIGNATURE Concludes Charity Auction Benefiting Families Affected by Autism

SEOUL, South Korea, July 22, 2021 /PRNewswire/ -- LG Electronics (LG) has pledged all proceeds from itsSTRONGER TOGETHER charity auction (July 8-18) to Sur les bancs de l'école, a French non-profit organization that has been supporting young people with Autism Spectrum Disorders (ASD) since 2008....

2021-07-23 09:00 8246

Kazia Calls for Increased Focus on Brain Cancer Research this GBM Awareness Day

SYDNEY, July 21, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a leading drug development company in the field of brain cancer, today recognizes Glioblastoma (GBM) Awareness Day and calls for a greater focus on research from industry, academia, and government in order ...

2021-07-21 22:00 11532

MedPharm Implements the Peregrine Connect NetSuite PSA Add-in for Microsoft Project to Accurately Forecast Revenue and Cut Manual Labor by 80%

IRVINE, Calif., July 21, 2021 /PRNewswire/ -- Peregrine Connect's NetSuite PSA Add-in for Microsoft Project has been selected by MedPharm to forecast its revenue recognition for ongoing and completed business projects.  MedPharm is a world-leading contract development and manufacturing organizati...

2021-07-21 09:00 994

OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology

TOKYO, July 20, 2021 /PRNewswire/ -- OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has raised ¥800 million in Series B financing led by TheUniversity of Tokyo Edge Capital Partners...

2021-07-20 23:00 1370

Harbour BioMed Appoints Yingying Chen, PhD, as Chief Financial Officer

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, July 20, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX:02142) announced the appointment of Dr. Yingying Chen as Chief Financial Officer (CFO). Dr. Chen will be responsible for leading the overall management of Finance & Investor Re...

2021-07-20 21:53 12713

Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy

* Kineta to leverage Samsung Biologics' development and manufacturing expertise to advance KVA12.1 to IND * Samsung Biologics San Francisco R&D center and South Korea headquarters to offer a seamless, end-to-end CDMO service INCHEON, South Korea and SEATTLE, July 20, 2021 /PRNewswire/ -- Sams...

2021-07-20 20:00 1391

Novotech Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials

HONG KONG, July 20, 2021 /PRNewswire/ -- Novotech Health Holdings Pte. Ltd. ("Novotech") joins a historic alliance of over one hundred life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The "Decent...

2021-07-20 13:10 1213

Within weeks of first COVID-19 outbreak, China's Qingdao Weida Biotechnology had switched all production capability over to PPE

QINGDAO, China, July 19, 2021 /PRNewswire/ -- On July 16, 2021, organized by the Information Office of the People's Government of Shandong Province, a delegation of journalists from foreign media organizations who were participating in the 2021 Qingdao Multinationals Summit (QMS) paid a visit to ...

2021-07-20 07:15 1268

ImmVira Launches Pilot-scale Production Line to Expedite the Advancement of Next-generation OV Clinical Trials

SHENZHEN, China, July 18, 2021 /PRNewswire/ -- On July 18, 2021, ImmVira inaugurated a pilot-scale production line inShenzhen and officially initiated its in-house production of our next-generation oncolytic viruses (OV) used for IND applications and Phase I/II clinical trials. Leveraging a strat...

2021-07-19 08:30 1535

Kintor Pharmaceutical Receives Emergency Use Authorization for Proxalutamide for the Treatment of COVID-19 in Paraguay

SUZHOU, China, July 16, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced thatParaguay's Ministry of Public Health and Social Welfare (MSPBS) has granted an emerg...

2021-07-16 14:41 36443
1 ... 155156157158159160161 ... 207